Mia's Feed
Medical News & Research

Winter Respiratory Viruses and Their Link to Heart Attacks and Strokes: Why Vaccination Is Key

Winter Respiratory Viruses and Their Link to Heart Attacks and Strokes: Why Vaccination Is Key

Share this article

Emerging research shows that winter respiratory viruses like flu and COVID-19 can trigger heart attacks and strokes. Vaccination and lifestyle measures are key to reducing this risk during the season.

2 min read

As winter arrives, bringing colder weather and a rise in respiratory illnesses, concerns extend beyond just the common cold or flu. Emerging research highlights how seasonal viruses such as influenza and COVID-19 can significantly increase the risk of heart attacks and strokes, especially during this time of year.

Studies suggest that infections from respiratory viruses can act as triggers in individuals already vulnerable due to traditional risk factors like high cholesterol, high blood pressure, obesity, diabetes, and aging. These viruses may not directly cause heart attacks or strokes but can set off an inflammatory chain reaction that destabilizes existing plaques in blood vessels, leading to clots and vascular blockages.

A comprehensive meta-analysis examining over 11,000 scientific papers spanning four decades found that catching the flu increases the short-term risk of a heart attack by approximately fivefold and the risk of stroke by nearly five times. COVID-19 infection also appears to elevate these risks, although the precise extent remains under investigation. Other viruses, such as RSV, enteroviruses, and cytomegaloviruses, are also linked to increased cardiovascular events, albeit to a lesser degree.

The process involves viral infection-induced inflammation damaging vulnerable blood vessel plaques. This triggers blood clot formation, which can obstruct blood flow, resulting in a heart attack or stroke. Fragments of the COVID virus have even been identified inside blood clots, further supporting this connection.

Given these findings, vaccination emerges as a vital preventive measure. Evidence from clinical trials indicates that flu vaccines significantly reduce the risk of cardiovascular events, especially in people with existing heart conditions. COVID vaccines may offer similar benefits by decreasing the severity or likelihood of infections that can activate harmful inflammation.

Preventative actions are particularly crucial for older adults and those with pre-existing health issues, as they are more susceptible. It is recommended that at-risk groups receive annual flu and COVID vaccines, and older individuals or those with medical conditions should also consider RSV vaccination.

Adopting a healthy lifestyle—regular exercise, balanced diet, and managing risk factors—remains essential for everyone. Maintaining heart health through these measures, combined with vaccination, can substantially reduce the risk of severe cardiovascular events during the winter virus season.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Device Advances Human Eye Transplant Technology

Researchers develop a groundbreaking portable eye-ECMO device to preserve donor eyes, paving the way for future human eye transplants and vision restoration.

New Female-Specific Pathway in Brown Fat Enhances Energy Burn in Women

A groundbreaking study reveals a female-specific mechanism in brown adipose tissue that enhances energy expenditure. Centered on PGC-1α and estrogen, this pathway offers promising avenues for obesity and diabetes therapies. Source: https://medicalx.press.com/news/2025-09-female-specific-mechanism-energy-expenditure.html

Exploring the Connection Between Fatigue and Breast Cancer Recurrence

Emerging research indicates a measurable link between fatigue and inflammation in breast cancer survivors, shedding light on new approaches for personalized fatigue management to reduce recurrence risk.

Innovative Biomaterial Demonstrates Potential to Reverse Heart Aging

A new hybrid biomaterial developed by researchers shows promise in reversing age-related changes in heart tissue by targeting the extracellular matrix, opening new possibilities for regenerative therapies.